The Food and Drug Administration is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression.
involving women who experienced severe depression after having a baby, the drug improved symptoms — such as anxiety, trouble sleeping, loss of pleasure, low energy, guilt or social withdrawal — as early as three days after the first pill.
The medication was jointly developed by pharmaceutical companies Biogen and Sage Therapeutics. If approved, it will become the first treatment for postpartum depression that can be taken at home. The only other available option is that the FDA approved in 2019. It requires patients to stay in a hospital for two-and-a-half days.
Dr. Samantha Meltzer-Brody, director of the University of North Carolina’s Center for Women’s Mood Disorders and an investigator on both zuranolone trials, said the data so far are"incredibly encouraging and very exciting," though she cautioned that the trials only followed patients for 45 days.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
First-ever pill for postpartum depression is up for FDA approval this weekThe FDA is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression. If approved, it will become the first treatment that can be taken at home.
Read more »
Extreme temperatures aren’t stopping food pantry volunteers from providing cold, fresh foodHundreds of cars line up the River City Community Center parking lot every Wednesday, waiting for a helping hand. The record-breaking heat is not stopping volunteers from helping people get the food they need.
Read more »
Food stamps: First August SNAP payment worth up to $1,691 to arrive in Michigan tomorrowEligible Supplemental Nutrition Assistance Program recipients in Michigan will start receiving a maximum payment of $1,691 tomorrow.
Read more »
Scherzer beats White Sox in his Rangers debutFour of the first five Sox batters reached base in a 3-run first inning.
Read more »
FDA, DEA Blame Demand, Drug Makers for ADHD Med ShortageIn a letter to the public the FDA and the DEA contend that unprecedented demand, potential overprescribing, and underproduction are the primary reasons for the national shortage of stimulants to treat ADHD.
Read more »
Thousands of birth control pills recalled, may be ineffective, FDA warnsA total of 4,179 boxes of Tydemy brand birth control pills have been recalled, which amounts to about 350,000 tablets that might be less effective at stopping pregnancy.
Read more »